MicroRNAs (miRNAs) are a type of small non-coding RNAs that regulate cognate mRNA expressions at the post-transcriptional stage. Although several miRNAs are known to be involved in various biological processes, including developmental timing, patterning, embryogenesis, differentiation and organogenesis, growth control, and apoptosis, many target genes and the functions of most miRNAs are still unclear. Since there is only a partial complementarity between miRNAs and their targets in animal cells, it is difficult to identify the specific target genes for a given miRNA and elucidate its function. In this study, we confirmed that bone morphogenetic protein receptor II (BMPRII) is a direct target of miR-21, and also showed that the protein level of BMPRII correlates inversely with the amount of miR-21 in PC3 and Lncap cells. These findings suggest that miR-21 may have a potential role in regulating the malignancy and metastatic abilities of prostate cancer cells and in self-renewal of stem cells by regulating the expression of BMPRII.
Introduction
MicroRNAs (miRNAs) are a recently discovered class of approximately 21 nucleotide long RNA molecules that negatively regulate the expression of target mRNAs at the post-transcriptional level [1 -3] . Their importance in a variety of biological processes has become apparent during the last decade [4] [5] [6] [7] . Recent advances in miRNA research have provided evidence of aberrant gene expressions in different kinds of diseases such as cancer, cardiovascular diseases, psychological disorders, and others [8 -11] .
MiR-21 has been identified as the most expressed miRNA in a number of profiling experiments designed for the detection of miRNAs dysregulated in cancer. MiR-21 is abundantly expressed in most cancer cell lines [12] . It has been found that miR-21 plays a role in various fields such as development, oncology, stem cell biology, and aging. It is one of the most studied miRNAs [13] . Since there is only a partial complementarity between miRNAs and their targets in animal cells, it is difficult to identify the specific target genes for a given miRNA and elucidate its function. Although miR-21expression is generally associated with cancer, it has several other direct targets such as programmed cell death 4, tropomyosin 1, and phosphatase and tensin homolog deleted on chromosome 10 [14] [15] [16] .
Bone morphogenetic proteins (BMPs) are the members of the tumor growth factor (TGF)-b super family. BMP-Smad signaling regulates stem cell renewal, cell proliferation, differentiation, migration, and apoptosis, and controls embryo development and postnatal tissue homoeostasis [17] [18] [19] . BMPs exert their effects via a heteromeric receptor complex, which consists of two types of serine-threonine kinase transmembrane receptors. BMPRII is the type 2 receptor of BMPs; mutations in BMPRII lead to the development of hereditary pulmonary hypertension, and its knockout results in early embryonic lethality [20, 21] . BMPRII initiates intracellular signaling in response to the following specific ligands: BMP-2, BMP-4, BMP-6, BMP-7, growth and differentiation factor (GDF)-5, and GDF-6 [22] . BMPRII plays a critical role in the maintenance of normal pulmonary vascular physiology, cell proliferation, cell death, and stem cell differentiation and self-renewal [23, 24] . Loss of BMPRII expression in both prostate cancer tissues and cell lines has been shown to be associated with the progression of prostate cancer [25] .
In this study, we investigated whether BMPRII is the direct target of miR-21 and found that the protein level of BMPRII correlated inversely with miR-21 levels in PC3 and Lncap cells, two different kinds of prostate cancer cells with different malignancy and metastasis status. These findings suggest that miR-21 might be involved in the progression of prostate cancer and self-renewal of stem cells.
Materials and Methods
Cell culture 293T, PC3, and Lncap cells were obtained from the Cell Bank, China Academy of Science (Shanghai, China). Cells were cultured in Dulbecco's modified Eagle's medium (DMEM), DMEM/F12, and RPMI 1640 medium (Invitrogen, Carlsbad, USA), respectively. All the media were supplemented with 10% fetal bovine serum (FBS, HyClone Laboratories, Logan, USA) and maintained at 378C and in 5% CO 2 .
Construction of 3
0 -untranslated region-luciferase plasmid The two upstream and the two downstream predicted binding sites on the 3 0 -untranslated region (UTR) of BMPRII along with $1 kb of the contiguous sequences were cloned into the EcoRI-NdeI and NdeI-PstI sites of pGL3 (Promega, Madison, USA) and designated as Luc-BS12-BMPRII and Luc-BS34-BMPRII, respectively. In addition, the two downstream predicted binding sites, which also included 1 kb of the contiguous sequences, were cloned into the NdeI and PstI sites of Luc-BS12-BMPRII; this plasmid was designated as Luc-B1234-BMPRII. The following primers were used for plasmid construction. BS12-sense primer: 5 0 -TCAG AATTCAATCAGTTTGGACCAGTTTC-3 0 ; BS12-antisense primer: 5 0 -TCACATATGGTTTGATAGCAGC CCTTC-3 0 ; BS34-sense primer: 5 0 -TCA CATATGAATCC TCGTAAGTATGTAAAGGA-3 0 ; BS34-antisense primer:
Luciferase assay For reporter assays, the cells were transiently cotransfected into 12-well plates with the luciferase vector Luc-BS12-BMPRII, Luc-BS34-BMPRII, Luc-B1234-BMPRII, or pGL3 reporter plasmid and either miR-21-mimcs (Ambion, Austin, USA) or miR-21-antisense oligonucleotide (ASO, Takara, Dalian, China) using lipofectamine TM 2000 (Invitrogen, Carlsbad, USA). Seeding region-mutated miR-21 mimics and miR-21-ASO were used as negative controls (NC-mimics and NC-ASO). To determine the transfection efficiency, pRL-SV40 plasmid was cotransfected as a control. Reporter assays were performed at 24 h post-transfection using the Dual-luciferase assay system (Promega, Madison, USA).
RNA isolation
Total RNA was isolated using Trizol Reagent (Invitrogen, Carlsbad, USA) according to the manufacturer's instructions. Contaminating genomic DNA was removed from the isolated RNA by treatment with amplification-grade DNase I (Invitrogen, Carlsbad, USA) for 2 h at 378C. RNA was precipitated with 3 M NaAc ( pH 5.5) and 2.5 volumes of ethanol and quantified spectrophotometrically.
NCode
TM quantitative polymerase chain reaction Quantitative polymerase chain reaction (PCR) was performed on unamplified total RNA using the NCode TM quantitative PCR kit (Invitrogen) according to the manufacturer's instructions. The differences in the miRNA expression between samples were determined using the relative quantification method. The PCR program is: 948C for 5 min; 948C for 15 s, 578C for 20 s, 728C for 10 s, 45 cycles; 728C for 2 min. And we did the melting curve procedure at the first time. The cycle threshold (Ct) values of the samples were normalized to the Ct values of glyceraldehyde 3-phosphate dehydrogenase (GAPDH), a housekeeping gene. The fold difference in the gene expressions of the samples was calculated using the equation 2 2DDCt .
Protein extraction and western blot
Protein was extracted with protein extraction reagent (Sigma, St. Louis, USA) according to the manufacturer's instructions. Then proteins were suspended in 1Â SDS loading buffer (Sigma, St. Louis, USA). And 20 mg proteins were separated on 12% SDS-polyacrylamide gels and transferred to polyvinylidene difluoride membrane. Then, the membrane was blocked with Poly(butylene succinate-co-terephthalate) containing 5% milk powder for 1 h at room temperature, followed by incubation overnight at 48C in TBS containing 0.1% Tween20, 1% milk powder and primary antibodies. Primary antibodies were detected using a peroxidase-coupled secondary antibody (1:2000, Sigma, St. Louis, USA) and chemiluminescence (Pierce, Rockford, USA). The following primary antibodies were used: rabbit anti-BMPRII (1:1000, Santa Cruz Biotechnology, Santa Cruz, USA) and GAPDH (1:2000, Abcam, Cambridge, UK).
Results

BMPRII is a predicted target of miR-21
Using the TargetScan software (http://www.targetscan. org/), it was predicted that there are 4 binding sites in the 3 0 UTR region of the BMPRII gene [ Fig. 1(A) ]. These four predicted binding sites were located at the 527, 945, 7296, and 7480 nt in the 3 0 UTR region of the BMPRII gene, respectively. The free energy values for the 4 BSs were approximately 219.3, 219.2, 221.4, and 226.8 Kcal/mol [ Fig. 1(B) ]. Generally, all the miR-21 seed region (2 -8 nt position) and corresponding pairing sites make near perfect complementarity, which is a common accepted principle in miRNA target prediction.
Two predicted binding sites on BMPRII are broadly conserved among vertebrates By comparing the human sequence of the BSs for interspecies homology, we found that two of the predicted miR-21 binding sequences, BS3 and BS4, are highly conserved among several vertebrate species, indicating this kind of regulation via miR-21 is a conserved mechanism for fine tuning its expression level in evolution (Fig. 2) .
Luciferase assay confirmed that BMPRII could be regulated by miR-21 Since the distance between the two upstream and the two downstream predicted binding sites was very long, we first cloned these two upstream and downstream sites separately along with $1 kb of the contiguous sequences and designated them B12 and B34, respectively. To determine the predicted binding sites that could be regulated by miR-21, the fragment containing the sequences for BS12 and BS34 was cloned separately into the 3 0 UTR region of the luciferase gene in a reporter vector pGL3. Subsequently, the two luciferase reporter vectors with the miR-21 response elements were transfected into 293T cells. We used the seeding region-mutated miR-21-mimics as the negative control (NC-mimics). NC-mimics control or miR-21-mimics were also cotransfected into these cells. Then, the activity of luciferase and Renilla in these cells was measured. It was found that miR-21 decreased the luciferase activity of the reporter vector containing either the miR-21 response elements B12 or B34 [ Fig. 3(A,B) ]. These data suggest that miR-21 could regulate the expression of BMPRII by binding to not only the two downstream conserved binding sites but also the two upstream predicted binding sites. To further investigate whether all the four predicted binding sites are required for the regulation of miR-21, all the four binding sites regions were cloned into the 3 0 UTR of the luciferase gene in the pGL3 plasmid. The results of the luciferase assay revealed that the expression of luciferase gene containing the predicted binding sites was downregulated by $50% in the presence of the miR-21 mimics. The downregulation of the luciferase gene was $30% in the presence of ASO-miR-21 [ Fig. 3(C) ]. Taken together, these results confirmed that BMPRII is regulated by miR-21.
The protein level of BMPRII correlates inversely with the amount of miR-21 in PC3 and Lncap cells Using NCode TM quantitative PCR, it was found that the expression of miR-21 is approximately eight times higher in PC3 cells than in Lncap cells [ Fig. 4(A) ]. On the other hand, the results of the western blot showed that the expression of BMPRII was lower in PC3 cells than in Lncap cells [ Fig. 4(B,C) ]. These data showed that the protein level of BMPRII correlates inversely with the miR-21 levels in PC3 and Lncap cells.
BMPRII has several predicted conserved site on its 3 0 UTR region for miRNA families broadly conserved among vertebrates Since BMPRII has a 7816-nt long 3 0 UTR region, we hypothesized that it might be regulated by several miRNAs at the post transcription level. We used TargetScan software to predict miRNAs which could bind on the 3 0 UTR region of BMPRII. As predicted, a lot of miRNAs were predicted to have binding sites on the 3 0 UTR region of BMPRII. Among them, several conserved sites for miRNA families that are broadly conserved among vertebrates have been predicted (Fig. 5) . These data provided a clue that BMPRII might be regulated by different miRNAs under different condition.
Discussion
BMPs are one of the largest groups of cytokines within the TGF-b super family. BMPs were originally identified as molecules that regulate the growth and differentiation of bones and cartilage [26, 27] . BMPRII is a type II serine/threonine kinase receptor of BMPs that is required to initiate the intracellular signaling pathway. Mutations in BMPRII lead to hereditary pulmonary hypertension, and knock out of BMPRII results in early embryonic lethality [28,] . miR-21 is well-known as an oncogene in a variety of tumor types. A previous study has determined several targets of miR-21, most of which are associated with cell growth [29] . In this study, we provided evidence that BMPRII is a direct target of miR-21 and has four predicted target sites in its 3 0 UTR region. Among the four predicted binding sites, two downstream sites are conserved among several vertebrate species. Our data showed that miR-21 could regulate the expression of BMPRII by binding to not only the two downstream conserved binding sites but also the two upstream predicted binding sites. We speculate that these four binding sites could function together to enhance the regulation ability of miR-21. We confirmed that BMPRII, which is associated with self-renewal and differentiation of stem cells, is a target of miR-21. These data suggest that miR-21 not only regulates cell growth and stem cell differentiation but is also involved in many other biological processes.
In this study, it was found that the protein level of BMPRII correlated inversely with miR-21 levels in PC3 and Lncap cells. LncaP cells are androgen-sensitive human prostate adenocarcinoma cells derived from the left supraclavicular lymph node metastasis. PC3 cell lines were originally derived from the advanced androgen-independent bone metastasis. The metastatic and malignancy potential of PC3 cells is higher than that of Lncap cells, which have moderate metastatic potential [30] . Our data showed that the expression level of miR-21 was higher in PC3 than in Lncap cells, suggesting a possibility that miR-21 could have potential therapeutic applications in cancer. BMPRII has been reported to be expressed at low levels in prostate cancers, and loss of BMPRII in both prostate cancer tissues and cell lines have been shown to have an association with the progression of prostate cancers [31] . Our study suggested that miR-21 might be associated with the malignance and metastatic abilities of cancer cells by regulating BMPRII.
In conclusion, we have confirmed that BMPRII is a direct target of miR-21. In addition, we found that the protein level of BMPRII correlates inversely with miR-21 levels in PC3 and Lncap cells. The results of this study provided further evidence of the extensive role of miR-21 in the regulation of prostate cancer progression. BMPRII is a target of miR-21
